| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.23 | 4e-07 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.15 | 0.001 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | -0.11 | 0.02 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | 0.11 | 0.03 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | 0.069 | 0.1 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | 0.066 | 0.1 |
| mRNA | Nutlin-3 | CCLE | pan-cancer | AAC | 0.071 | 0.1 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | 0.06 | 0.2 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | -0.057 | 0.2 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | 0.042 | 0.4 |